Genmab A/S (Nasdaq: GMAB) today announced updated results from two ongoing clinical trials evaluating the efficacy and safety of epcoritamab-bysp, a T-cell engaging antibody administered ...

Ever had that moment before guests arrive when you look around and wonder what they’ll notice first? We all want our homes to ...

"India’s stance in the changing world order is clear. India stands for a cooperative and rule-based global system; but at the ...

In April 2018, experienced pilot Philip O’Driscoll crashed his helicopter, a Bell UH-1H registered VH-HUE, during a lifting ...

As the world observes World Lymphoma Awareness Day on September 15th, it 39;s a timely reminder of the ongoing battle against lymphomas, a group of cancers affecting the lymphatic system, especially ...

These are the high-tech tools transforming our beauty routines. Read on for the best ever tested, with IPL devices, ...

New two- and three-year EPCORE ® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in patients with DLBCL and FL Latest EPCORE DLBCL-3 ...

The operator is testing a hybrid-powered base station in Japan that offers a look at how operators can check carbon footprint ...

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

This Special Report covers multiple developing stories across India. A survey by the Karnataka Monitoring and Evaluation ...